Amedisys Inc (NASDAQ:AMED) shares were up 1.2% during mid-day trading on Wednesday . The company traded as high as $55.22 and last traded at $55.18. Approximately 209,692 shares changed hands during trading, a decline of 37% from the average daily volume of 334,246 shares. The stock had previously closed at $54.55.

A number of research analysts have issued reports on AMED shares. Zacks Investment Research upgraded Amedisys from a “hold” rating to a “buy” rating and set a $61.00 price target for the company in a research report on Friday, January 12th. SunTrust Banks reiterated a “buy” rating and set a $70.00 price target on shares of Amedisys in a research report on Friday, November 10th. Craig Hallum reiterated a “buy” rating and set a $68.00 price target (up previously from $55.00) on shares of Amedisys in a research report on Thursday, November 9th. Jefferies Group reiterated a “buy” rating and set a $60.00 price target on shares of Amedisys in a research report on Thursday, October 12th. Finally, Mizuho reiterated a “buy” rating and set a $65.00 price target (up previously from $55.00) on shares of Amedisys in a research report on Wednesday, November 8th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $60.64.

The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16. The firm has a market cap of $1,905.89, a price-to-earnings ratio of 26.87, a price-to-earnings-growth ratio of 1.17 and a beta of 0.73.

Several institutional investors have recently made changes to their positions in AMED. LS Investment Advisors LLC lifted its holdings in shares of Amedisys by 233.1% in the fourth quarter. LS Investment Advisors LLC now owns 3,564 shares of the health services provider’s stock valued at $188,000 after buying an additional 2,494 shares during the period. Quantitative Systematic Strategies LLC acquired a new stake in shares of Amedisys in the third quarter valued at $205,000. Amalgamated Bank acquired a new stake in shares of Amedisys in the second quarter valued at $246,000. NorthCoast Asset Management LLC acquired a new stake in shares of Amedisys in the third quarter valued at $262,000. Finally, Fox Run Management L.L.C. acquired a new stake in shares of Amedisys in the fourth quarter valued at $269,000. Institutional investors and hedge funds own 94.97% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Amedisys (AMED) Trading Up 1.2%” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.dailypolitical.com/2018/02/09/amedisys-amed-trading-up-1-2.html.

About Amedisys

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.